Antifungal Stewardship

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Infection Prevention and Antimicrobial Stewardship Conference Series session will take place on Monday, March 6, 2023 at 12:00 p.m. Attendance will only be available virtually through Zoom.

Activity Information

Needs Statement

Infectious disease physicians, fellows, residents, medical students, advanced practice providers, and other healthcare professionals in the Texas Medical Center need to receive regular updates on advances in the field of infection prevention. The series will examine a wide range of topics, such as hospital-acquired infections, opportunistic infections, multi-drug antimicrobial resistance, and the principles of antimicrobial stewardship. The series also aims to expand the knowledge of learners, promote guideline-based infection prevention, enhance decision-making surrounding antibiotic usage, and improve patient outcomes.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

  • Recognize the most clinically relevant mechanisms of resistance in Gram-positive and Gram-negative bacteria.
  • Describe a translational approach to molecular mechanisms of resistance.
  • Discuss precision medicine strategies for multiple-drug resistant organisms with important stewardship
    repercussions.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Other Health Professionals

Specialties

  • Internal Medicine

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Director

  1. Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Vice Chair, QI and Innovations
    Baylor College of Medicine

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Luis Ostrosky-Zeichner, M.D., FACP

    Luis Ostrosky-Zeichner, M.D., FACP

    Professor of Medicine and Epidemiology, Memorial Hermann Endowed Chair, Division Chief of Infectious Diseases, Chief Epidemiology Officer
    UTHealth Houston McGovern Medical School, Memorial Hermann Healthcare System

    Disclosure:
    • Research Support: Astellas; Cidara; Pfizer; Pulmocide; Scynexi
    • Consultancy: Cidara; F2G; Gilead; GSK; Merck; Pfizer; Viracor

Activity Director

  1. Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Vice Chair, QI and Innovations
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE

    Vice Chair, QI and Innovations
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Patrycja Ashley, M.D.

    Patrycja Ashley, M.D.

    Infectious Diseases Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Anthony Febres-Aldana, M.D.

    Anthony Febres-Aldana, M.D.

    Infectious Diseases Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Prathit Kulkarni, M.D., FACP

    Prathit Kulkarni, M.D., FACP

    Assistant Professor, Assistant Chief of Medicine, Associate Program Director of the Infectious Disease Fellowship
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

    Disclosure:
    • Research Support (including clinical trials) & the principal or named investigator: Vessel Health, Inc.
  5. Jose Serpa-Alvarez, M.D., M.S.

    Jose Serpa-Alvarez, M.D., M.S.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Teena Huan Xu, M.D.

    Teena Huan Xu, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Luis Ostrosky-Zeichner, M.D., FACP

Luis Ostrosky-Zeichner, M.D., FACP

Professor of Medicine and Epidemiology, Memorial Hermann Endowed Chair, Division Chief of Infectious Diseases, Chief Epidemiology Officer UTHealth Houston McGovern Medical School, Memorial Hermann Healthcare System

Health Topics

You May Also Be Interested In

Upcoming
Citywide Infectious Diseases Conference
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Citywide Infectious Diseases Conference
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
In Person
Live Stream
Upcoming
Michael E. DeBakey VAMC/CTRID Research Seminar Series
Activity duration: 1 hr
Activity Available In Person / Activity Available in via Streaming
Credit 1.00 Continuing Medical Education Credits Available